ASSOCIATION OF SGLT2 INHIBITORS WITH STROKE IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Mi, D. [1 ]
Pan, P. [1 ]
Chen, S. [1 ]
Chen, S. [1 ]
Peng, F. [1 ]
机构：
[1] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
SO067 / #
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [31] Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Wang, Xin
    Zhang, Fengyi
    Zhang, Yufeng
    Zhang, Jiayi
    Sheng, Yingli
    Wang, Wenbo
    Li, Yujie
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (12) : 2013 - 2025
  • [32] The Role of SGLT2 Inhibitors in Heart Failure: A Systematic Review and Meta-Analysis
    Tsampasian, Vasiliki
    Baral, Ranu
    Chattopadhyay, Rahul
    Debski, Maciej
    Joshi, Shruti S.
    Reinhold, Johannes
    Dweck, Marc R.
    Garg, Pankaj
    Vassiliou, Vassilios S.
    CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [33] The effect of SGLT2 inhibitors on kidney stones; a systematic review and meta-analysis
    Sisakht, Ali Rahnama
    Kamkar, Parvin
    Darzi, Mohammad Mehdi
    Madani, Mohammad Hamidi
    Arismani, Rasoul Jafari
    Gharebakhshi, Farshad
    Behi, Mahdi
    Mardanparvar, Hossein
    Haghighi, Ramin
    JOURNAL OF RENAL INJURY PREVENTION, 2024,
  • [34] Effects of SGLT2 inhibitors on the cardiovascular outcomes in patients with cancer: a systematic review and meta-analysis
    Liu, L.
    Chen, H. H.
    Kuo, H. H.
    Lin, P. L.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [35] Impact of SGLT2 Inhibitors on Mortality Risk in Type 2 Diabetes Mellitus and Coronary Artery Disease: A Systematic Review and Meta-Analysis
    Gonzales, Antony
    Collantes-Silva, Nicole
    Arambulo-Castillo, Sebastian
    Ortiz-Benique, Zhamanda N.
    Munoz-Moreno, Juan Manuel
    Alarcon, Esteban
    CIRCULATION, 2024, 150
  • [36] GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis
    Karagiannis, Thomas
    Tsapas, Apostolos
    Athanasiadou, Eleni
    Avgerinos, Ioannis
    Liakos, Aris
    Matthews, David R.
    Bekiari, Eleni
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 174
  • [37] Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: A systematic review and meta-analysis
    El Masri, Dana
    Ghosh, Samiran
    Jaber, Linda A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 83 - 92
  • [38] SGLT2 inhibitors in type 2 diabetes, a systematic review and meta-analysis of cardiovascular outcome trials balancing their benefits against their risks
    Marilly, E.
    Cottin, J.
    Cabrera, N.
    Cornu, C.
    Boussageon, R.
    Moulin, P.
    Lega, J. C.
    Gueyffier, F.
    Cucherat, M.
    Grenet, G.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 168 - 168
  • [39] Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Shi-di Zhao
    Ling Zhou
    Yi-ying Tao
    Yue Yue
    Jia-xin Wang
    Lei Shen
    Guo-yuan Lu
    Yong-fu Hang
    International Journal of Diabetes in Developing Countries, 2022, 42 : 178 - 190
  • [40] Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
    Zhao, Shi-di
    Zhou, Ling
    Tao, Yi-ying
    Yue, Yue
    Wang, Jia-xin
    Shen, Lei
    Lu, Guo-yuan
    Hang, Yong-fu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 178 - 190
12345